Bo Wang
Impact in
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Molecular Biology top 1%
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- Circular RNAs in diseases 16
- RNA modifications and cancer 9
- RNA Research and Splicing 7
-
- MicroRNA in disease regulation 40
- Cancer-related molecular mechanisms research 15
- Co-authors
- Peter Tontonoz (8 shared papers)Kalpana Ghoshal (9 shared papers)Shu‐Hao Hsu (7 shared papers)Samson T. Jacob (7 shared papers)Huban Kutay (6 shared papers)Phillip Kantharidis (4 shared papers)David A. Ford (8 shared papers)Xin Rong (5 shared papers)
- Journals
- Oncotarget (6 papers)Hepatology (4 papers)Cell Cycle (3 papers)Frontiers in Physiology (3 papers)Cell Death and Disease (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bo Wang
167 papers receiving 8.0k citations
Bo Wang's Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 2.8k
- Molecular Biology 4.2k
- Biochemistry 356
- Hepatology 315
- Oncology 915
Countries citing papers authored by Bo Wang
This map shows the geographic impact of Bo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Wang more than expected).
Fields of papers citing papers by Bo Wang
This network shows the impact of papers produced by Bo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Wang. The network helps show where Bo Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 173 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver Hit paper breakdown → | 2012 | 630 |
| 2 | Liver X receptors in lipid signalling and membrane homeostasis Hit paper breakdown → | 2018 | 511 |
| 3 | 2009 | 410 | |
| 4 | 2018 | 338 | |
| 5 | 2009 | 303 | |
| 6 | 2009 | 266 | |
| 7 | 2013 | 252 | |
| 8 | 2005 | 249 | |
| 9 | 2011 | 243 | |
| 10 | 2018 | 236 | |
| 11 | 2011 | 231 | |
| 12 | 2010 | 222 | |
| 13 | 2009 | 204 | |
| 14 | 2012 | 198 | |
| 15 | 2015 | 173 | |
| 16 | 2003 | 169 | |
| 17 | 2017 | 147 | |
| 18 | 2018 | 145 | |
| 19 | 2020 | 130 | |
| 20 | 2017 | 100 |
About Bo Wang
Bo Wang is a scholar working on Molecular Biology, Cancer Research, Physiology, Oncology and Surgery, having authored 173 papers that have together received 8.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (40 papers), Circular RNAs in diseases (16 papers), Cancer-related molecular mechanisms research (15 papers), Adipose Tissue and Metabolism (14 papers), RNA modifications and cancer (9 papers), Lipid metabolism and biosynthesis (8 papers), RNA Research and Splicing (7 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Cancer Research (2.8k citations), Molecular Biology (4.2k citations), Biochemistry (356 citations), Hepatology (315 citations) and Oncology (915 citations). Bo Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Peter Tontonoz, Kalpana Ghoshal, Shu‐Hao Hsu, Samson T. Jacob, Huban Kutay, Phillip Kantharidis, David A. Ford, Xin Rong, Shoumei Bai and Sarmila Majumder. Their work appears in journals such as Oncotarget, Hepatology, Cell Cycle, Frontiers in Physiology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.